GlassScriptPhysician profile
Sharon Bassi
NPI 1033388277
$1,854.97
in general payments reported to CMS, 2019-2025
11 companies · $1,273 in 2025
The $1,273 reported for 2025 was more than what 77% of Pain Medicine (Physical Medicine & Rehabilitation) providers received nationally (typical 2025 total: $400).
See the full distribution for Pain Medicine (Physical Medicine & Rehabilitation)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $27.97 · 2021: $82.19 · 2022: $21.78 · 2023: $433 · 2024: $17.05 · 2025: $1,273.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,077 · Travel and Lodging: $646.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,077.17 |
| Travel and Lodging | $645.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Si-Bone, INC. | $680.14 | 2025 | |
| Wenzel Spine, INC. | $516.11 | 2025 | Primalok |
| Zap Surgical Systems, INC. | $253.69 | 2023 | Zap-X Treatment Delivery Software, Zap-X Treatment Planning Software, Zap-X Mv Imager |
| Abbvie INC. | $176.66 | 2023-2025 | Botox, Qulipta, Ubrelvy |
| Stryker Corporation | $82.19 | 2021 | |
| Boston Scientific Corporation | $33.46 | 2025 | Intracept |
| Pacira Therapeutics, INC. | $27.97 | 2020 | |
| Baxter Healthcare | $25.71 | 2025 | Floseal |
| Pacira Pharmaceuticals Incorporated | $21.78 | 2022 | |
| Novocure INC. | $20.21 | 2023 | Optune |
| Fisher & Paykel Healthcare INC | $17.05 | 2024 | Fisher & Paykel Healthcare |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sharon Bassi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.